Relationship of serum adiponectin with blood lipids, HbA1c, and hs-CRP in type II diabetic postmenopausal women

Journal of Clinical Laboratory Analysis

Volumn 21, Issue 3, 2007, Pages 197-200

  Goodarzi, Mohammad Taghi ^a   Babaahmadi Rezaei, Hossein ^a   Kadkhodaei Eliaderani, Manizheh ^b   Haddadinezhad, Shahram ^a  

^a HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adiponectin; Glycated hemoglobin; hs CRP

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; ARTICLE; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FATTY ACID OXIDATION; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; INSULIN RESISTANCE; LIPID BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; POSTMENOPAUSE; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPONECTIN; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBINS; HUMANS; LIPIDS; MIDDLE AGED; POSTMENOPAUSE; PREDICTIVE VALUE OF TESTS;

EID: 34249285524     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20175     Document Type: Article

References (21)

1. Snehalatha C, Mukesh B, Simon M, Viswanathan V, Haffner SM, Ramachandran A. Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians. Diabetes Care 2003;26: 3226-3229.
2. Kondo H, Shimomura I, Matsukawa Y, et al. Association of adiponectin mutation with type 2 diabetes. Diabetes 2002;51: 2325-2328.
3. Mantzoros C, Li T, Manson J, Meigs J, Hu F. Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile and reduced inflammation in women with type 2 diabetes. J Clin Endocrinol Metab 2005;372:1-22.
4. Tschritter O, Fritsche A, Thamer C, et al. Plasma adiponectin concentration predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 2003;52:239-243.
5. Zoccali C, Mallamaci F, Tripepi G, et al. Adiponectin metabolic risk factors, and cardiovascular events among patient with end-stage renal disease. J Am Soc Nephrol 2002;13:134-141.
6. Kazumi T, Kawaguchi A, Sakai K, Hirano T, Yoshino G. Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Diabetes Care 2002;25:971-976.
7. Daimon M, Oizumi T, Saitoh T, et al. Decreased serum levels of adiponectin are a risk factor for the progression to type II diabetes in Japanese population: the Funagata study. Diabetes 2003;26: 2015-2020.
8. Lindsay RS, Funahashi T, Hanson RL, et al. Adiponectin and development of type 2 diabetes in Pima Indian population. Lancet 2002;360:57-58.
9. Spranger J, Kroke A, Mohlig M, et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003;361:226-228.
10. Chandran M, Phillips SA, Ciaraldi T, Henry RR. Adiponectin more than just another fat cell hormone? Diabetes Care 2003; 26:2442-2450.
11. Berg AH, Combs TP, Scherer PE. ACR30/adiponectin: an adipokine regulating glucose and lipids metabolism. Trends Endocrinol Metab 2002;13:84-89.
12. Jaleel F, Jaleel A, Aftab J, Rahman MA. Relationship between adiponectin and blood lipids in diabetic type 2 postmenopausal women with and without complication of ischemic heart disease. Clin Chim Acta 2006;370:76-81.
13. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other category of glucose intolerance. Diabetes 1979;28:1039-1057.
14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-502.
15. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86:1930-1935.
16. Matsubara M, Maruoka S, Katayose. Decreased plasma adiponectin concentration in women with dyslipidemia. J Clin Endocrinol Metab 2002;87:2764-2769.
17. Ryan AS, Berman DM, Nicklas BJ, Katayose S. Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care 2003;26:2383-2388.
18. Hotta K, Funahashi T, Bodkin NL, et al. Circulating concentration of adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkey. Diabetes 2001;50:1126-1133.
19. Stefan N, Vozarova B, Funahashi T, et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosin phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in human. Diabetes 2002;51:1884-1888.
20. Zurawska-Klis M, Drzewoski J. Inflammatory markers and adiponectin plasma level in patients with type 2 diabetes. Pol Arch Med Wewn 2005;114:652-657.
21. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941-946.